Phase III study of HP-3150 in patients with cancer pain
Latest Information Update: 21 Jan 2022
At a glance
- Drugs Diclofenac (Primary)
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 20 Jan 2022 Status changed from recruiting to completed.
- 24 Jul 2017 New trial record